![Riku Heikki Rautsola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Riku Heikki Rautsola
Directeur/Membre du Conseil chez
Famar SA
Profil
Riku Heikki Rautsola is currently Director at Famar SA since 2026.
Former positions include President & Chief Executive Officer at VIRxSYS Corp., Chief Executive Officer at Borean Pharma ApS, Chief Executive Officer at Cosmix molecular biologicals GmbH, President & Chief Executive Officer at Corden Pharma SpA, President & Chief Executive Officer at Laurantis Pharma Oy from 2011 to 2013, Director at Biotie Therapies Oy from 2004 to 2011, Director at Signature Capital LLC, Managing Director at Corden Pharma GmbH, and Principal at Fresenius SE & Co. KGaA, Boehringer Ingelheim GmbH, and Beiersdorf AG.
Education includes a doctorate from Ludwig-Maximilians-Universität München.
Postes actifs de Riku Heikki Rautsola
| Sociétés | Poste | Début |
|---|---|---|
Famar SA
 Famar SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization servicing the pharmaceutical industry | Directeur/Membre du Conseil | 01/01/2024 |
Anciens postes connus de Riku Heikki Rautsola
| Sociétés | Poste | Fin |
|---|---|---|
Corden Pharma SpA
 Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Manufactures sterile liquid dosage forms for injectable use | Directeur Général | 01/08/2019 |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur Général | 01/01/2013 |
| BIOTIE THERAPIES CORP | Directeur/Membre du Conseil | - |
Corden Pharma GmbH
 Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services for complex modalities, from early clinical phases to commercialization | Directeur Général | - |
Signature Capital LLC
 Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Directeur/Membre du Conseil | - |
Formation de Riku Heikki Rautsola
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Health Technology |
Beiersdorf AG
 Beiersdorf AG Household/Personal CareConsumer Non-Durables Manufactures and wholesales skin and body care products | Consumer Non-Durables |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Famar SA
Famar SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization servicing the pharmaceutical industry | Health Technology |
Borean Pharma ApS
 Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals drugs and protein engineering services | Health Technology |
Cosmix molecular biologicals GmbH
 Cosmix molecular biologicals GmbH BiotechnologyHealth Technology Develops peptides for therapeutics | Health Technology |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corden Pharma SpA
Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Manufactures sterile liquid dosage forms for injectable use | Health Technology |
Corden Pharma GmbH
Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services for complex modalities, from early clinical phases to commercialization | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
